|
|
||||||||
Ann Thorac Surg 1992;54:661-668
© 1992 The Society of Thoracic Surgeons
Division of Cardiovascular Surgery, The Toronto Hospital and University of Toronto, Toronto, Ontario, Canada
* Address reprint requests to Dr David, 200 Elizabeth St, 13EN219, Toronto, Ontario M5G 2C4, Canada.
The Hancock II bioprosthesis was used for heart valve replacement in 614 patients front 1982 to 1990. Aortic valve replacement (AVR) was performed in 376 patients, mitral valve replacement (MVR) in 195, and aortic and mitral valve replacement (DVR) in 43. The mean age was 62.7 years, and 78% of all patients were in New York Heart Association functional class III or IV before operation. Coronary artery bypass graft was necessary in 232 patients and replacement of ascending aorta in 55. There were 31 operative deaths (AVR, 4%; MVR, 6%; DVR, 9%). Follow-up was complete in 98.5% of the patients and extended from 12 to 103 months, with a mean of 49 months. At the last follow-up, 85% of the patients were in New York Heart Association class I or II. The actuarial survival at 8 years was 79% ± 3% for AVR, 68% ± 4% for MVR, and 65% ± 10% for DVR. The freedom from stroke at 8 years was 93% ± 2% for AVR, 83% ± 5% for MVR, and 90% ± 5% for DVR. At the end of 8 years 96% ± 1% of all patients were free from endocarditis, 92% ± 1% were free from primary tissue failure, and 89% ± 3% were free from reoperation. The actuarial freedom from valve-related death at 8 years was 98% ± 1% for AVR, 86% ± 5% for MVR, and 91% ± 6% for DVR. Hemodynamic assessment was obtained by Doppler echocardiography in all operative survivors and demonstrated satisfactorily effective valve orifices and transvalvular gradients. The clinical results obtained with the Hancock II bioprosthesis have been gratifying, particularly in the aortic position. This bioprosthesis is our biological valve of choice.
This article has been cited by other articles:
![]() |
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, S. Schiffelers, J. Wallrath, and G. Wahl The Mosaic porcine bioprosthesis: Role of age on clinical performance in aortic position J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1440 - 1448.e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aziz, J. S. Lawton, H. S. Maniar, M. K. Pasque, R. J. Damiano Jr, and M. R. Moon Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis-Patient Mismatch Ann. Thorac. Surg., October 1, 2010; 90(4): 1202 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, S. Armstrong, and M. Maganti Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Ann. Thorac. Surg., September 1, 2010; 90(3): 775 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text] |
||||
![]() |
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bridges, S. M. O'Brien, J. C. Cleveland, E. B. Savage, J. S. Gammie, F. H. Edwards, E. D. Peterson, and F. L. Grover Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1012 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Moon, M. K. Pasque, N. A. Munfakh, S. J. Melby, J. S. Lawton, N. Moazami, J. E. Codd, T. D. Crabtree, H. B. Barner, and R. J. Damiano Jr Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival Ann. Thorac. Surg., February 1, 2006; 81(2): 481 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rizzoli, T. Bottio, G. Thiene, G. Toscano, and D. Casarotto Long-term durability of the Hancock II porcine bioprosthesis J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, G. Thiene, E. Pettenazzo, P. Ius, U. Bortolotti, G. Rizzoli, C. Valfre, D. Casarotto, and M. Valente Hancock II bioprosthesis: A glance at the microscope in mid-long-term explants J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 99 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text] |
||||
![]() |
G. Dellgren, T. E. David, E. Raanani, S. Armstrong, J. Ivanov, and H. Rakowski Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Banbury, D. M. Cosgrove III, J. D. Thomas, E. H. Blackstone, J. Rajeswaran, J. E. Okies, and R. M. Frater Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis Ann. Thorac. Surg., May 1, 2002; 73(5): 1460 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Fradet, N. Bleese, J. Burgess, and P. C. Cartier Mosaic valve international clinical trial: early performance results Ann. Thorac. Surg., May 1, 2001; 71(2007): S273 - S277. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, J. Ivanov, S. Armstrong, C. M. Feindel, and G. Cohen Late results of heart valve replacement with the Hancock II bioprosthesis J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0268 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pibarot and J. G. Dumesnil Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1131 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Wong, M. E. Legget, S. C. Greaves, B. G. Barratt-Boyes, F. P. Milsom, and P. J. Raudkivi Early experience with the Mosaic bioprosthesis: a new generation porcine valve Ann. Thorac. Surg., June 1, 2000; 69(6): 1846 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. von Kodolitsch, O. Simic, A. Schwartz, C. Dresler, R. Loose, M. Staudt, J. Ostermeyer, A. Haverich, and C. A. Nienaber Predictors of Proximal Aortic Dissection at the Time of Aortic Valve Replacement Circulation, November 9, 1999; 100(90002): II-287 - II-294. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cohen, T. E. David, J. Ivanov, S. Armstrong, and C. M. Feindel THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 273 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Sommers and T. E. David Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus Ann. Thorac. Surg., June 1, 1997; 63(6): 1608 - 1612. [Abstract] [Full Text] |
||||
![]() |
G. T. Christakis, C. D. Joyner, C. D. Morgan, S. E. Fremes, K. J. Buth, J. Y. Sever, V. Rao, K. P. Panagiotopoulos, P. M. Murphy, and B. S. Goldman Left Ventricular Mass Regression Early After Aortic Valve Replacement Ann. Thorac. Surg., October 1, 1996; 62(4): 1084 - 1089. [Abstract] [Full Text] |
||||
![]() |
W. R. Eric Jamieson, A. I. Munro, R. T. Miyagishima, P. Allen, L. H. Burr, and G. F. O. Tyers Carpentier-edwards standard porcine bioprosthesis: Clinical performance to seventeen years Ann. Thorac. Surg., October 1, 1995; 60(4): 999 - 1007. [Abstract] [PDF] |
||||
![]() |
J. Fernandez, C. Chen, J. Gu, O. B. Brdlik, G. W. Laub, M. M. Murphy, M. S. Adkins, W. A. Anderson, and L. B. McGrath Comparison of low-pressure versus standard-pressure fixation carpentier-Edwards bioprosthesis Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S205 - S210. [Abstract] [PDF] |
||||
![]() |
U. Bortolotti, A. Milano, E. Mossuto, E. Mazzaro, G. Thiene, and D. Casarotto Porcine valve durability: A comparison between Hancock standard and Hancock II bioprostheses Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S216 - S220. [Abstract] [PDF] |
||||
![]() |
T. E. David, S. Armstrong, and Z. Sun The Hancock II bioprosthesis at ten years Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S229 - S234. [Abstract] [PDF] |
||||
![]() |
W. R. Eric Jamieson, L. H. Burr, G. Frank, O. Tyers, R. T. Miyagishima, M. T. Janusz, H. Ling, G. J. Fradet, J. MacNab, F. Chan, et al. Carpentier-Edwards supraannular porcine bioprosthesis: Clinical performance to twelve years Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S235 - S240. [Abstract] [PDF] |
||||
![]() |
W. R. Eric Jamieson, L. H. Burr, R. T. Miyagishima, G. J. Fradet, M. T. Janusz, G. Frank, O. Tyers, J. MacNab, and F. Chan Structural deterioration in Carpentier-Edwards standard and supraannular porcine bioprostheses Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S241 - S247. [Abstract] [PDF] |
||||
![]() |
M. D. Lemieux, W. R. Eric Jamieson, R. W. Landymore, J. G. Dumesnil, J. Metras, A. Ian Munro, G. Raymond, G. Frank, O. Tyers, P. C. Cartier, et al. Medtronic intact porcine bioprosthesis: Clinical performance to seven years Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S258 - S263. [Abstract] [PDF] |
||||
![]() |
T. E. David, C. M. Feindel, J. Bos, Z. Sun, H. E. Scully, and H. Rakowski Aortic valve replacement with a stentless porcine aortic valveA six-year experience J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1030 - 1036. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |